Foghorn Therapeutics Statistics
NASDAQ: FHTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.72-0.06 (-3.37%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Foghorn Therapeutics by the numbers
Foghorn Therapeutics has a market capitalization of $103.1 million based on 59.96M shares outstanding. Its trailing P/E ratio is 19.1. The stock trades 31.1% below its 50-day average and 61.1% below its 200-day average.
Average daily trading volume is 843.73K shares, or about $1.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FHTX valuation vs. peer median
| Metric | FHTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $103.14M | $101.76M | +1% |
| Avg. volume | 843.73K | 548.47K | +54% |
Peer median across 8 companies: GNLX, ORGO, NERV, AKBA, CNTN, UNCY, BGM, SPRB.
Valuation
- Market cap
- $103.14M
- P/E (TTM)
- 19.11
- Price / sales (latest FY)
- 3.34
- EPS (TTM)
- $0.09
- Shares outstanding
- 59.96M
Price and trading
- Previous close
- 1.78
- Open
- 1.74
- Day range
- 1.66 – 1.80
- 52-week range
- 1.66 – 7.61
- 52-week change
- -62.77%
- Beta
- —
- Volume
- 919.93K
- Average volume
- 843.73K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 103.14M
- Pe
- 19.11
- Forward Pe
- -1.27
- Eps
- 0.09
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.61
- Week52 Low
- 1.66
- Avg Volume
- 843.73K
- Shares Outstanding
- 59.96M
- Ma50
- 2.50
- Ma200
- 4.42
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -77.40%
- Pct From52w Low
- 3.61%